Nuclear EGFR as a molecular target in cancer

Radiotherapy and Oncology

Volumn 108, Issue 3, 2013, Pages 370-377

  Brand, Toni M ^a   Iida, Mari ^a   Luthar, Neha ^a   Starr, Megan M ^a   Huppert, Evan J ^a   Wheeler, Deric L ^a  

^a UNIVERSITY OF WISCONSIN   (United States)

Author keywords

Cancer; Nuclear EGFR; Resistance

Indexed keywords

CELECOXIB; CETUXIMAB; CISPLATIN; CYCLIN D1; CYCLINE; DASATINIB; DNA DEPENDENT PROTEIN KINASE; ENZASTAURIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; GEFITINIB; LAPATINIB; LATENT MEMBRANE PROTEIN 1; MIDOSTAURIN; MUCIN 1; NUCLEAR EPIDERMAL GROWTH FACTOR RECEPTOR; NUCLEAR RECEPTOR COACTIVATOR 2; UNCLASSIFIED DRUG;

ANGIOGENESIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RESISTANCE; CANCER THERAPY; CELL MEMBRANE; CELL NUCLEUS; CELL PROLIFERATION; DISEASE COURSE; DNA REPAIR; HUMAN; NEOPLASM; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION RESPONSE; RADIOSENSITIVITY; RADIOSENSITIZATION; REVIEW; THERAPY RESISTANCE;

BCRP; BREAST CANCER RESISTANT PROTEIN; CANCER; COX-2; CYCLOOXYGENASE-2; DNA PROTEIN KINASE; DNA-PK; EGFR; EPIDERMAL GROWTH FACTOR RECEPTOR; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HNSCC; INM; INNER NUCLEAR MEMBRANE; INOS; LATENT MEMBRANE PROTEIN 1; LMP1; MUC1; MUCIN-1; NITRIC OXIDE SYNTHASE; NLS; NON-SMALL CELL LUNG CANCER; NPC; NSLC; NUCLEAR EGFR; NUCLEAR LOCALIZATION SEQUENCE; NUCLEAR LOCALIZATION SIGNAL; NUCLEAR PORE COMPLEX; ONM; OUTER NUCLEAR MEMBRANE; PCNA; PNPASE; POLYNUCLEOTIDE PHOSPHORYLASE; PROLIFERATING CELL NUCLEAR ANTIGEN; RESISTANCE; RHA; RNA HELICASE A; TAT INTERACTING PROTEIN; TIF2; TIP3; TKI; TNBC; TRANSCRIPTIONAL INTERMEDIARY FACTOR 2; TRIPLE NEGATIVE BREAST CANCER; TYROSINE KINASE INHIBITOR;

ANIMALS; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; HUMANS; NEOPLASMS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-AKT; PYRAZOLES; RADIATION TOLERANCE; RECEPTOR, EPIDERMAL GROWTH FACTOR; SULFONAMIDES;

EID: 84887019788     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.06.010     Document Type: Review

References (76)

1. Y. Yarden, and M.X. Sliwkowski Untangling the ErbB signalling network Nat Rev Mol Cell Biol 2 2001 127 137
2. The scent of Nobel Prize success Funct Neurol 19 2004 217 218
3. M.D. Marmor, K.B. Skaria, and Y. Yarden Signal transduction and oncogenesis by ErbB/HER receptors Int J Radiat Oncol Biol Phys 58 2004 903 913
4. T.A. Libermann, H.R. Nusbaum, N. Razon, R. Kris, I. Lax, and H. Soreq Amplification and overexpression of the EGF receptor gene in primary human glioblastomas J Cell Sci Suppl 3 1985 161 172
5. T.A. Libermann, H.R. Nusbaum, N. Razon, R. Kris, I. Lax, and H. Soreq Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin Nature 313 1985 144 147
6. T.A. Libermann, N. Razon, A.D. Bartal, Y. Yarden, J. Schlessinger, and H. Soreq Expression of epidermal growth factor receptors in human brain tumors Cancer Res 44 1984 753 760
7. D. Veale, T. Ashcroft, C. Marsh, G.J. Gibson, and A.L. Harris Epidermal growth factor receptors in non-small cell lung cancer Br J Cancer 55 1987 513 516
8. R.R. Weichselbaum, E.J. Dunphy, M.A. Beckett, A.G. Tybor, W.J. Moran, and M.E. Goldman Epidermal growth factor receptor gene amplification and expression in head and neck cancer cell lines Head Neck 11 1989 437 442
9. J.D. Sato, T. Kawamoto, A.D. Le, J. Mendelsohn, J. Polikoff, and G.H. Sato Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors Mol Biol Med 1 1983 511 529
10. T. Kawamoto, J.D. Sato, A. Le, J. Polikoff, G.H. Sato, and J. Mendelsohn Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody Proc Natl Acad Sci USA 80 1983 1337 1341
11. H. Sunada, B.E. Magun, J. Mendelsohn, and C.L. MacLeod Monoclonal antibody against epidermal growth factor receptor is internalized without stimulating receptor phosphorylation Proc Natl Acad Sci USA 83 1986 3825 3829
12. T.M. Brand, M. Iida, C. Li, and D.L. Wheeler The nuclear epidermal growth factor receptor signaling network and its role in cancer Discov Med 12 2011 419 432
13. Y.N. Wang, H. Yamaguchi, J.M. Hsu, and M.C. Hung Nuclear trafficking of the epidermal growth factor receptor family membrane proteins Oncogene 29 2010 3997 4006
14. W. Han, and H.W. Lo Landscape of EGFR signaling network in human cancers: biology and therapeutic response in relation to receptor subcellular locations Cancer Lett 318 2012 124 134
15. Y.N. Wang, H. Yamaguchi, L. Huo, Y. Du, H.J. Lee, and H.H. Lee The translocon Sec61beta localized in the inner nuclear membrane transports membrane-embedded EGF receptor to the nucleus J Biol Chem 285 2010 38720 38729
16. Y.N. Wang, H. Wang, H. Yamaguchi, H.J. Lee, H.H. Lee, and M.C. Hung COPI-mediated retrograde trafficking from the Golgi to the ER regulates EGFR nuclear transport Biochem Biophys Res Commun 399 2010 498 504
17. H.W. Lo, M. Ali-Seyed, Y. Wu, G. Bartholomeusz, S.C. Hsu, and M.C. Hung Nuclear-cytoplasmic transport of EGFR involves receptor endocytosis, importin beta1 and CRM1 J Cell Biochem 98 2006 1570 1583
18. H.J. Liao, and G. Carpenter Role of the Sec61 translocon in EGF receptor trafficking to the nucleus and gene expression Mol Biol Cell 18 2007 1064 1072
19. S.C. Hsu, and M.C. Hung Characterization of a novel tripartite nuclear localization sequence in the EGFR family J Biol Chem 282 2007 10432 10440
20. Y.N. Wang, H.H. Lee, H.J. Lee, Y. Du, H. Yamaguchi, and M.C. Hung Membrane-bound trafficking regulates nuclear transport of integral epidermal growth factor receptor (EGFR) and ErbB-2 J Biol Chem 287 2012 16869 16879
21. E.R. Eldredge, G.M. Korf, T.A. Christensen, D.C. Connolly, M.J. Getz, and N.J. Maihle Activation of c-fos gene expression by a kinase-deficient epidermal growth factor receptor Mol Cell Biol 14 1994 7527 7534
22. S.Y. Lin, K. Makino, W. Xia, A. Matin, Y. Wen, and K.Y. Kwong Nuclear localization of EGF receptor and its potential new role as a transcription factor Nat Cell Biol 3 2001 802 808
23. H.W. Lo, S.C. Hsu, M. Ali-Seyed, M. Gunduz, W. Xia, and Y. Wei Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway Cancer Cell 7 2005 575 589
24. N. Hanada, H.W. Lo, C.P. Day, Y. Pan, Y. Nakajima, and M.C. Hung Co-regulation of B-Myb expression by E2F1 and EGF receptor Mol Carcinog 45 2006 10 17
25. H.W. Lo, X. Cao, H. Zhu, and F. Ali-Osman Cyclooxygenase-2 is a novel transcriptional target of the nuclear EGFR-STAT3 and EGFRvIII-STAT3 signaling axes Mol Cancer Res 8 2010 232 245
26. L.Y. Hung, J.T. Tseng, Y.C. Lee, W. Xia, Y.N. Wang, and M.L. Wu Nuclear epidermal growth factor receptor (EGFR) interacts with signal transducer and activator of transcription 5 (STAT5) in activating Aurora-A gene expression Nucleic Acids Res 36 2008 4337 4351
27. S. Jaganathan, P. Yue, D.C. Paladino, J. Bogdanovic, Q. Huo, and J. Turkson A functional nuclear epidermal growth factor receptor, SRC and stat3 heteromeric complex in pancreatic cancer cells Plos One 6 2011 e19605
28. W.C. Huang, Y.J. Chen, L.Y. Li, Y.L. Wei, S.C. Hsu, and S.L. Tsai Nuclear translocation of epidermal growth factor receptor by Akt-dependent phosphorylation enhances breast cancer-resistant protein expression in gefitinib-resistant cells J Biol Chem 286 2011 20558 20568
29. K. Dittmann, C. Mayer, and H.P. Rodemann Inhibition of radiation-induced EGFR nuclear import by C225 (Cetuximab) suppresses DNA-PK activity Radiother Oncol 76 2005 157 161
30. K. Dittmann, C. Mayer, B. Fehrenbacher, M. Schaller, U. Raju, and L. Milas Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase J Biol Chem 280 2005 31182 31189
31. A. Psyrri, Z. Yu, P.M. Weinberger, C. Sasaki, B. Haffty, and R. Camp Quantitative determination of nuclear and cytoplasmic epidermal growth factor receptor expression in oropharyngeal squamous cell cancer by using automated quantitative analysis Clin Cancer Res 11 2005 5856 5862
32. H.W. Lo, W. Xia, Y. Wei, M. Ali-Seyed, S.F. Huang, and M.C. Hung Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer Cancer Res 65 2005 338 348
33. W. Xia, Y. Wei, Y. Du, J. Liu, B. Chang, and Y.L. Yu Nuclear expression of epidermal growth factor receptor is a novel prognostic value in patients with ovarian cancer Mol Carcinog 48 2009 610 617
34. M. Hoshino, H. Fukui, Y. Ono, A. Sekikawa, K. Ichikawa, and S. Tomita Nuclear expression of phosphorylated EGFR is associated with poor prognosis of patients with esophageal squamous cell carcinoma Pathobiology 74 2007 15 21
35. C.F. Li, F.M. Fang, J.M. Wang, C.C. Tzeng, H.C. Tai, and Y.C. Wei EGFR nuclear import in gallbladder carcinoma: nuclear phosphorylated EGFR upregulates iNOS expression and confers independent prognostic impact Ann Surg Oncol 2011
36. A.M. Traynor, T.M. Weigel, K.R. Oettel, D.T. Yang, C. Zhang, and K. Kim Nuclear EGFR expression predicts poor survival in resected non-small cell lung cancer J Thorac Oncol 2012
37. G. Liccardi, J.A. Hartley, and D. Hochhauser EGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatment Cancer Res 71 2011 1103 1114
38. C. Li, M. Iida, E.F. Dunn, A.J. Ghia, and D.L. Wheeler Nuclear EGFR contributes to acquired resistance to cetuximab Oncogene 28 2009 3801 3813
39. S.C. Hsu, S.A. Miller, Y. Wang, and M.C. Hung Nuclear EGFR is required for cisplatin resistance and DNA repair Am J Transl Res 1 2009 249 258
40. N.J. Curtin DNA repair dysregulation from cancer driver to therapeutic target Nat Rev Cancer 12 2012 801 817
41. R.K. SchmidtUllrich, R.B. Mikkelsen, P. Dent, D.G. Todd, K. Valerie, and B.D. Kavanagh Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation Oncogene 15 1997 1191 1197
42. S.M. Huang, J.M. Bock, and P.M. Harari Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck Cancer Res 59 1999 1935 1940
43. S.M. Huang, J. Li, and P.M. Harari Monoclonal antibody blockade of the epidermal growth factor receptor in cancer therapy Cancer Chemother Biol Response Modif 19 2001 339 352
44. K. Dittmann, C. Mayer, R. Kehlbach, and H.P. Rodemann Radiation-induced caveolin-1 associated EGFR internalization is linked with nuclear EGFR transport and activation of DNA-PK Mol Cancer 7 2008 69
45. K. Dittmann, C. Mayer, B. Fehrenbacher, M. Schaller, R. Kehlbach, and H.P. Rodemann Nuclear EGFR shuttling induced by ionizing radiation is regulated by phosphorylation at residue Thr654 FEBS Lett 584 2010 3878 3884
46. K. Dittmann, C. Mayer, G. Wanner, R. Kehlbach, and H.P. Rodemann The radioprotector O-phospho-tyrosine stimulates DNA-repair via epidermal growth factor receptor- and DNA-dependent kinase phosphorylation Radiother Oncol 84 2007 328 334
47. K. Dittmann, C. Mayer, B. Fehrenbacher, M. Schaller, R. Kehlbach, and H.P. Rodemann Nuclear epidermal growth factor receptor modulates cellular radio-sensitivity by regulation of chromatin access Radiother Oncol 99 2011 317 322
48. K. Dittmann, C. Mayer, R. Kehlbach, and H.P. Rodemann The radioprotector Bowman-Birk proteinase inhibitor stimulates DNA repair via epidermal growth factor receptor phosphorylation and nuclear transport Radiother Oncol 86 2008 375 382
49. G. Wanner, C. Mayer, R. Kehlbach, H.P. Rodemann, and K. Dittmann Activation of protein kinase C epsilon stimulates DNA-repair via epidermal growth factor receptor nuclear accumulation Radiother Oncol 86 2008 383 390
50. Y.L. Yu, R.H. Chou, C.H. Wu, Y.N. Wang, W.J. Chang, and Y.J. Tseng Nuclear EGFR suppresses ribonuclease activity of polynucleotide phosphorylase through DNAPK-mediated phosphorylation at serine 776 J Biol Chem 287 2012 31015 31026
51. D. Wang, and S.J. Lippard Cellular processing of platinum anticancer drugs Nat Rev Drug Discov 4 2005 307 320
52. D.L. Wheeler, S. Huang, T.J. Kruser, M.M. Nechrebecki, E.A. Armstrong, and S. Benavente Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members Oncogene 27 2008 3944 3956
53. H.J. Liao, and G. Carpenter Cetuximab/C225-induced intracellular trafficking of epidermal growth factor receptor Cancer Res 69 2009 6179 6183
54. C. Li, M. Iida, E.F. Dunn, and D.L. Wheeler Dasatinib blocks cetuximab- and radiation-induced nuclear translocation of the epidermal growth factor receptor in head and neck squamous cell carcinoma Radiother Oncol 97 2010 330 337
55. D.L. Wheeler, M. Iida, T.J. Kruser, M.M. Nechrebecki, E.F. Dunn, and E.A. Armstrong Epidermal growth factor receptor cooperates with Src family kinases in acquired resistance to cetuximab Cancer Biol Ther 8 2009 696 703
56. D.L. Wheeler, E.F. Dunn, and P.M. Harari Understanding resistance to EGFR inhibitors-impact on future treatment strategies Nat Rev Clin Oncol 7 2010 493 507
57. T.M. Brand, M. Iida, and D.L. Wheeler Molecular mechanisms of resistance to the EGFR monoclonal antibody cetuximab Cancer Biol Ther 11 2011
58. H.P. Kim, Y.K. Yoon, J.W. Kim, S.W. Han, H.S. Hur, and J. Park Lapatinib, a dual EGFR and HER2 tyrosine kinase inhibitor, downregulates thymidylate synthase by inhibiting the nuclear translocation of EGFR and HER2 Plos One 4 2009
59. Y.L. Yu, R.H. Chou, J.H. Liang, W.J. Chang, K.J. Su, and Y.J. Tseng Targeting the EGFR/PCNA signaling suppresses tumor growth of triple-negative breast cancer cells with cell-penetrating PCNA peptides Plos One 8 2013
60. C. Oliveras-Ferraros, A. Vazquez-Martin, E. Lopez-Bonet, B. Martin-Castillo, S. Del Barco, and J. Brunet Growth and molecular interactions of the anti-EGFR antibody cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: new prospects in the treatment of triple-negative/basal-like breast cancer Int J Oncol 33 2008 1165 1176
61. Z. Weihua, R. Tsan, W.C. Huang, Q. Wu, C.H. Chiu, and I.J. Fidler Survival of cancer cells is maintained by EGFR independent of its kinase activity Cancer Cell 13 2008 385 393
62. Q. Wang, G. Villeneuve, and Z. Wang Control of epidermal growth factor receptor endocytosis by receptor dimerization, rather than receptor kinase activation EMBO Rep 6 2005 942 948
63. M. Iida, T.M. Brand, D.A. Campbell, C. Li, and D.L. Wheeler Yes and Lyn play a role in nuclear translocation of the epidermal growth factor receptor Oncogene 2012
64. L. Milas Cyclooxygenase-2 (COX-2) enzyme inhibitors as potential enhancers of tumor radioresponse Semin Radiat Oncol 11 2001 290 299
65. H. Choy, and L. Milas Enhancing radiotherapy with cyclooxygenase-2 enzyme inhibitors: a rational advance? J Natl Cancer Inst 95 2003 1440 1452
66. T.J. Maier, K. Schilling, R. Schmidt, G. Geisslinger, and S. Grosch Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells Biochem Pharmacol 67 2004 1469 1478
67. M.I. Patel, K. Subbaramaiah, B.H. Du, M. Chang, P.Y. Yang, and R.A. Newman Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism Clin Cancer Res 11 2005 1999 2007
68. K.H. Dittmann, C. Mayer, P.A. Ohneseit, U. Raju, N.H. Andratschke, and L. Milas Celecoxib induced tumor cell radiosensitization by inhibiting radiation induced nuclear EGFR transport and DNA-repair: a COX-2 independent mechanism Int J Radiat Oncol Biol Phys 70 2008 203 212
69. S.C. Wang, Y. Nakajima, Y.L. Yu, W. Xia, C.T. Chen, and C.C. Yang Tyrosine phosphorylation controls PCNA function through protein stability Nat Cell Biol 8 2006 1359 1368
70. B.G. Bitler, A. Goverdhan, and J.A. Schroeder MUC1 regulates nuclear localization and function of the epidermal growth factor receptor J Cell Sci 123 2010 1716 1723
71. L.F. Huo, Y.N. Wang, W.Y. Xia, S.C. Hsu, C.C. Lai, and L.Y. Li RNA helicase A is a DNA-binding partner for EGFR-mediated transcriptional activation in the nucleus Proc Natl Acad Sci USA 107 2010 16125 16130
72. A. Li, C. Zhang, S. Gao, F. Chen, C. Yang, and R. Luo TIP30 loss enhances cytoplasmic and nuclear EGFR signaling and promotes lung adenocarcinogenesis in mice Oncogene 32 2013 2273 2281
73. Y. Shi, Y. Tao, Y. Jiang, Y. Xu, B. Yan, and X. Chen Nuclear epidermal growth factor receptor interacts with transcriptional intermediary factor 2 to activate cyclin D1 gene expression triggered by the oncoprotein latent membrane protein 1 Carcinogenesis 33 2012 1468 1478
74. H.J. Mackay, and C.J. Twelves Targeting the protein kinase C family: are we there yet? Nat Rev Cancer 8 2008 255-255
75. J.C. Brenner, M.P. Graham, B. Kumar, L.M. Saunders, R. Kupfer, and R.H. Lyons Genotyping of 73 Um-Scc head and neck squamous cell carcinoma cell lines Head Neck J Sci Spec 32 2010 417 426
76. M.E. Irwin, K.L. Mueller, N. Bohin, Y.B. Ge, and J.L. Boerner Lipid raft localization of EGFR alters the response of cancer cells to the EGFR tyrosine kinase inhibitor gefitinib J Cell Physiol 226 2011 2316 2328